logo
welcome
Reuters

Reuters

WHO approves Bavarian Nordic's mpox vaccine for adolescents

Reuters
Summary
Nutrition label

81% Informative

The WHO gave the Jynneos vaccine prequalification for adolescents on Oct. 8 .

The WHO declared mpox a global public health emergency for the second time in two years in August .

The Danish biotech firm is also preparing to conduct a clinical trial to assess the vaccine's safety in children aged two to 12 .

VR Score

92

Informative language

98

Neutral language

71

Article tone

formal

Language

English

Language complexity

64

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links